Hi Guest
Real-Time Quote
Enter Company or MFFresenius Kabi Oncology Ltd.
BSE | NSE
532545 FKONCO Group (B) BSE data
Add to Watchlist
| View Tips
How hot is this stock? © Rediff.com
* Computed on last 15 days' trading figures.
Report card
| Attribute | Value | Date |
|---|---|---|
| PE ratio | 39.54 | 18/05/12 |
| EPS (Rs) | 3.11 | Mar, 11 |
| Sales (Rs crore) | 128.32 | Dec, 11 |
| Face Value (Rs) | 1 | |
| Net profit margin (%) | 11.77 | Mar, 11 |
| Last dividend (%) | 20 | 18/05/06 |
| Return on average equity | 9.09 | Mar, 11 |
Research centre
Results Statement More
MFs invested in this company
AnnouncementsMore 
| 02 May | Publish Audited Results | |
| 02 Feb | Outcome of Board Meeting | |
| 02 Feb | Financial Results and Limited Review for Dec 31, 2011
 | |
| 21 Oct 2011 | Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
| |
| 20 Oct 2011 | Financial Results for Sep 30, 2011
| |
| 11 Aug 2011 | Financial Results for Jun 30, 2011
| |
| 27 Jun 2011 | Disinvestment of entire shareholding in subsidiary company | |
| 27 May 2011 | Fresenius Kabi Oncology Ltd. to focus on contract R and D and Manufacturing ActivitiesBR_TAG | |
| 27 May 2011 | Fixes Book Closure for AGM | |
| 26 May 2011 | Outcome of Board Meeting | |
Compare with
Add Your Stock Call
Thank you. Your call will appear shortly. Your returns will be updated at the end of the trading day. View All CallsAll MoneyWiz Pages
© Copyright 2012 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback